Join
Live feed
·
PRReleasevia Quantisnow
Galera Therapeutics Inc. logo

Galera Announces Primary Endpoint Met Statistical Significance in Corrected Topline Efficacy Data of Phase 3 ROMAN Trial of Avasopasem

ByQuantisnow·Wall Street's wire, on your screen.
GRTX· Galera Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GRTX (Galera Therapeutics Inc.) and more on Quantisnow.